Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-10-01, Stock:NVS, The news for the past five days is as follows:
2019-09-24: NEWS1: Novartis Securities Investment Ltd -- Moody's announces completion of a periodic review of ratings of Novartis AG.NEWS2: UPDATE 2-Novartis blames former AveXis executives for Zolgensma data manipulation.NEWS3: Bristol-Myers Squibb Company -- Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023.NEWS4: Biogen's Two MS Drugs Get CHMP Nod for Use in Pregnancy.NEWS5: Novartis blames former AveXis executives for Zolgensma data manipulation.NEWS6: Novartis blames former Avexis executives for Zolgensma manipulation.NEWS7: The Daily Biotech Pulse: Sandoz Recalls Ulcer Drug, Anchiano Strikes Agreement With ADT Pharma, Proteon Announces Reverse Merger.NEWS8: LabCentral co-founder issues ‘call to action' to biotechs on drug pricing.
2019-09-25: NEWS1: ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm.NEWS2: Rossini S.a r.l -- Moody's announces completion of a periodic review of ratings of Rossini S.a r.l.NEWS3: Bristol-Myers Squibb Company -- Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023.
2019-09-26: NEWS1: Here's Why Sanofi (SNY) is Outperforming Its Industry Of Late.NEWS2: Here's Why AstraZeneca (AZN) is Outperforming Its Industry.NEWS3: Achillion's Danicopan Gets Breakthrough Therapy Tag for PHN.NEWS4: Incyte Treats First Patient in Phase III Vitiligo Study.
2019-09-27: NEWS1: AbbVie (ABBV) Gets FDA Nod for Label Expansion of HCV Drug.NEWS2: Incyte (INCY) Stock Up 16% YTD on Strong Jakafi Performance.
2019-09-30: NEWS1: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Novartis AG Investors of Important Deadline in Securities Class Action First Filed by the Firm – NVS.NEWS2: CVS pulls Zantac and its generic brand over possible cancer link.NEWS3: Roche's (RHHBY) Rituxan Receives FDA Nod for Label Expansion.NEWS4: CBMG: Initiating Coverage of Cellular Biomedicine Group; Multiple Cell-Based Therapies to Treat Cancer and Degenerative Diseases….

Answer: Decrease